Error‐prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment
- 7 May 2020
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 147 (10) , 2658-2668
Abstract
Defects in DNA repair machinery play a critical role in the pathogenesis and progression of human cancer. When they occur, the tumor cells activate error‐prone mechanisms which lead to genomic instability and high mutation rate. These defects represent, therefore, a cancer Achilles'heel which could be therapeutically exploited by the use of DNA damage response inhibitors. Moreover, experimental and clinical evidence indicates that DNA repair deregulation has a pivotal role also in promoting immune recognition and immune destruction of cancer cells. Indeed, immune checkpoint inhibitors have received regulatory approval in tumors characterized by high genomic instability, such as melanomas and lung cancer. Here, we discuss how deregulation of DNA repair, through activation of error‐prone mechanisms, increases immune activation against cancer. Finally, we address the potential strategies to use DNA repair components as biomarkers and/or therapeutic targets to empower immune‐oncology treatment of human cancer.Keywords
This publication has 114 references indexed in Scilit:
- Diverse Mechanisms of Somatic Structural Variations in Human Cancer GenomesCell, 2013
- APOBEC3B is an enzymatic source of mutation in breast cancerNature, 2013
- Molecular Pathways: Understanding the Role of Rad52 in Homologous Recombination for Therapeutic AdvancementClinical Cancer Research, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Targeting Abnormal DNA Repair in Therapy-Resistant Breast CancersMolecular Cancer Research, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor ImmunityCancer Research, 2010
- Exonuclease Function of Human Mre11 Promotes Deletional Nonhomologous End JoiningJournal of Biological Chemistry, 2009
- DNA damage-induced cell death: lessons from the central nervous systemCell Research, 2007
- DNA Deamination in Immunity: AID in the Context of Its APOBEC Relatives2007